Abstract: Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C 18 column and gradient mobile phase was applied for good resolution of all peaks. The detection was achieved at 210 nm and 254 nm for Cinn/Pira and Cinn/Hept, respectively. The responses were linear over concentration ranges of 20-200, 20-1000 and 25-1000 µgmL -1 for Cinn, Pira, and Hept respectively. The proposed method was validated for linearity, accuracy, repeatability, intermediate precision, and robustness via statistical analysis of the data. The method was shown to be precise, accurate, reproducible, sensitive, and selective for the analysis of Cinn/Pira and Cinn/Hept in laboratory prepared mixtures and in pharmaceutical formulations.
Introduction
Cinnarizine (Cinn; Fig. 1a ) is a piperazine derivative with H 1 blocking (antihistaminic) and calcium channel blocking activity. 1, 2 Cinn is used for prevention and treatment of nausea and motion sickness. 2 Piracetam (Pira; Fig. 1b) 2-oxo-1-pyrrolidine acetamide 1 acts on the central nervous system. Pira has neuroprotective properties and improves neuroplasticity. At a vascular level, Pira appears to reduce erythrocyte adhesion to vascular endothelium, hinders vasospasm, and facilitates microcirculation. 2 Heptaminol acefyllinate (Hept; Fig. 1c ) 6-amino-2-methylheptan-2-ol salt of theophyllin-7-ylacetic acid is a peripheral vasodilator. 2 Several analytical methods have been reported for the determination of Cinn, Pira and Hept. Cinn samples, for example, have been analyzed by nonaqueous titration 3 and both colorimetric and derivative spectrometric methods have been reported for the determination of Cinn. [4] [5] [6] [7] Several liquid chromatographic (LC) methods have also been described in the literature for the determination of Cinn, such as LC with UV detection, [8] [9] [10] [11] [12] LC with mass spectrometric detection (MS), 13, 14 and LC with fluorimetric detection. 15 Additionally, electrophoresis with UV detection has also been used for the determination of Cinn. 16 Second-derivative synchronous fluorescence spectrometry was used for the determination of Cinn in pharmaceutical formulation 17 and thin-layer chromatographic (TLC)-densitometric method was applied for the simultaneous determination of Cinn and Pira in pharmaceutical preparations. 9 For the determination of Pira in pharmaceutical formulations several analytical methods have been reported including spectrometry, 18, 19 LC with UV detection, 3, [20] [21] [22] and LC with evaporative light scattering detection. 23 Pira was determined in rat plasma by LC with MS detection. 24 Furthermore, electrophoresis with UV detection, 25 GC, 26 and TLC-densitometric methods have also been used for the determination of Pira. 27, 28 Only a few analytical methods have been reported for the determination of Hept, such as LC with UV detection and spectrometric methods. The described methods have the advantage of simultaneous determination of Cinn and Hept. 29 The aim of the present study is to develop and validate an accurate and reproducible method for the simultaneous determination of Cinn/Pira and Cinn/ Hept in the presence of the reported degradation products of Cinn, namely benzophenone, benzhydrol, dibenzhydrol ether, and N-cinnamyl piperazine. 30 While the limited number of the reported LC methods with UV detection were capable of simultaneous determination of Cinn in its mixture with Pira 9 or Hep, 29 none of these methods have the ability to separate the degradation products of Cinn.
In conclusion, the previously published analytical techniques do not have the advantage of determining Cinn, Pira, and Hept in the presence of reported degradation products of Cinn.
experimental Instrumentation
The high-performance liquid chromatography (HPLC) system consisted of a Hewlett Packard, 1100 series (Waldbronn, Germany), diode array detector, and manual injector with 20 µL loop using Hypersil BDS C 18 column (5 µm, 200 × 4.6 mm) (Thermo, Bellefonte, PA, USA). The system was equipped with a UV-visible detector.
reagents and reference samples
Cinn and Pira standards of pharmaceutical grades were supplied from Misr, pharmaceutical company (Cairo-Egypt), while Hept standards were supplied from Memphis pharmaceutical company (CairoEgypt). The percent purity of these compounds were 99.54% ± 1.18% and 100.56% ± 1.17%, for Cinn and Pira, respectively, according to reference method rP-LC method development and validation BP, 3 and 100.00% ± 1.53% for Hept, according to the company method.
Degradation product of Cinn was benzophenone (Prolabo, France).
Benzhydrol, dibenzhydrol ether, and N-cinnamylpiperizine were prepared using the published procedure. [30] [31] [32] [33] Cinnaretam tablets of batch number 805072 contained 25 
Chromatographic conditions
Chromatographic separation was achieved on a Hypersil BDS C 18 column (5 µm, 200 × 4.6 mm) (Thermo, Bellefonte, PA, USA), with gradient elution using mobile phase A (acetonitrile: phosphate buffer (pH 6) (60:40 v/v)) and mobile phase B (acetonitrile: phosphate buffer (pH 6) (80:20 v/v)). The gradient programming is shown in Table 1 . The detection was done at 210 nm and 254 nm for Cinn/Pira and Cinn/Hept, respectively. The mobile phase was pumped through the column at a flow rate of 1 mLmin -1 . Separation was done at ambient temperature and the run time was 26 min.
Sample preparation
Twenty cinnaretam and sureptil tablets were ground and thoroughly mixed. An amount equivalent to 25/400 and 20/200 mg of Cinn/Pira and Cinn/Hept, respectively, were accurately weighed, transferred to separate 100 mL volumetric flask, and dissolved in 20 mL of acetonitrile. The solutions were sonicated for 10 min and then cooled. The solutions were diluted to volume with acetonitrile and filtered.
Procedure
Linearity and repeatability Accurately measured volumes of stock solutions 1, 2, and 3 equivalent to 0.2-2, 0.2-10, and 0.25-10 mg Cinn, Pira and Hept, respectively, were transferred into three separate series of 10 mL volumetric flasks and the solutions were completed to volume with acetonitrile. Each solution (20 µL) was injected in triplicates. A calibration plot for each drug was obtained by plotting the area under the peak against drug concentration 20-200, 20-1000, and 25-1000 µgmL -1 for Cinn, Pira and Hept, respectively, and regression equations were computed.
Assay of sample preparation The procedure previously described was repeated using a volume of standard solution equivalent to 0.2-2, 2-10, and 2-10 mg of Cinn, Pira and Hept, respectively, and the concentration of each drug was determined by the use of its corresponding regression equation.
Assay of drugs in laboratory prepared mixtures
The procedure described previously was repeated using a mixture of standard solutions equivalent to 0.2-2 mg Cinn, 0.2%-50% degradation products, and 2-5 mg of Pira and Hept. The concentration of each drug was determined by the use of its corresponding calibration equation.
Results and Discussion
The primary objective of the proposed LC method was the simultaneous determination of a mixture of Cinn/Pira and Cinn/Hept in the presence of the reported degradation products of Cinn. Degradation products of Cinn were:
1. Benzophenone (Prolabo, France). 2. Benzohydrol was prepared using the published procedure. 31 The purity was checked by m.p. and comparison of its IR spectrum (KBr) with that of benzophenone, which showed the appearance of O-H stretching band at 3300 cm -1 and disappearance of C=O stretching band at 1640 cm -1 . 3. Dibenzohydrol ether was prepared from benzhydrol using the published procedure. 32 The purity was checked by m.p. and comparison of its IR spectrum (KBr) with that of benzophenone and benzhydrol. It showed the absence of both C=O stretching and O-H stretching bands at 1640 cm
and 3300 cm -1 , respectively. 4. N-Cinnamylpiperizine was reported in the literature as a patent. 33 However a pure sample was prepared and its structure was confirmed by MS and 1 H-NMR. The MS chart revealed m/z 202 molecular ion, m/z 117 base peak and m/z 85.
The proposed method gave sharp, well resolved peaks of both drugs under investigation and the four known degradation products (Figs. 2 and 3) . None of the published chromatographic methods were capable of achieving the resolution of the six aforementioned components.
Method development
To optimize the LC assay parameters, the mobile phase composition was studied. A satisfactory separation of all peaks was obtained using gradient programming of mobile phase (Table 1) . Changing the proportion of the organic to aqueous ratio in mobile phases A and B by 10% achieved good resolution, but still prolonged retention time. High volume ratio of acetonitrile showed good separation of Cinn, however inadequate separation for Pira and Hept and prolonged retention time for other compounds. On the other side, lower volume ratio of acetonitrile showed adequate separation for Pira and Hept, and prolonged elution time for Cinn. High volume ratio of acetonitrile is still needed for the separation of N-Cinnamylpiperizine, which could not be separated at lower organic to aqueous ratio. This accounts for the composition of the mobile phase B (80% acetonitrile) and the need for gradient programming arouse to achieve separation for all 6 compounds under investigation. Different C 18 columns were tried, such as X-Terra (5 µm, 250 × 4.6 mm), Thermo Hypersil ODS (5 µm, 200 × 4.6 mm), and µ-Bondapack (5 µm, 300 × 4.6 mm). All columns achieved good resolution of all peaks under investigation. The advantage of Thermo Hypersil BDS C 18 (5 µm, 200 × 4.6 mm), however, was the less run time required for elution of the 6 studied peaks. The system suitability test results of the developed method are presented in Table 5 . rP-LC method development and validation (1) hept.
Analysis of pharmaceutical product
The proposed LC method was applied to the determination of Cinn/Pira and Cinn/Hept in tablets. Satisfactory results were obtained for Cinn/Pira and Cinn/Hept in good agreement with the labeled claimed Tables 2 and 3 .
Method validation Linearity
Linearity was studied for Cinn/Pira and Cinn/Hept by the proposed LC method. Linear relationship was obtained between area under the peak and each drug concentration. First order equation was used for the calibration. The analytical data for the regression equation are summarized in Tables 2 and 3 .
range The calibration ranges were established through consideration of the practical range necessary, according to each compound concentration present in pharmaceutical product, to give accurate, precise, and linear results. Wide calibration ranges were obtained for both Cinn/Pira and Cinn/Hept. The calibration range of each compound is given in Tables 2 and 3 . for Cinn and Pira, and by the company method for Hept, using student's t-test and F ratio. The obtained results are presented in Table 4 Tables 2 and 3 .
Accuracy and precision
Specificity Specificity is the ability of an analytical method to measure analyte response in the presence of interferences. Specificity of the proposed method and its good potential to determine both Cinn/Pira and Cinn/Hept in the presence of the four reported degradation products was assessed by the determination of both drugs in laboratory prepared mixture (Figs. 2 and 3) . It was Table 4 . results from the use of the proposed LC methods and reference methods for the analysis of Cinn/Pira and Cinn/ hept in Bulk material.
Recovery of cinn
Recovery of pira Recovery of Hept Reference method [3] Lc method Reference method [3] Lc rP-LC method development and validation Tables 2 and 3 .
robustness The robustness of the proposed LC method was assessed by the ability to remain unaffected by small changes in experimental conditions (flow rate, mobile phase, and temperature). Changing flow rate by ±0.2, temperature by ±5 °C, and fine changes of aqueous to organic ratio by 10% did not affect the resolution of all peaks, proof of the method robustness.
Limits of quantification and limit of detection
The limit of quantification (LOQ) and detection (LOD) were defined as the concentration for which the signal-to-noise ratios (S/N) were ten and three, respectively. The values obtained, which were averages from six replicates, are given in Tables 2  and 3 .
Chromatographic performance parameters
System suitability parameters were calculated according to USP 2011. 34 resolution factor (r) Resolution is a measure of the degree of separation between adjacent peaks. A value of 1.5 for resolution implies a complete separation of two compounds. In the present work, the resolution value for the separation of each compound was greater than 1.5 and is represented in Table 5 .
Selectivity factor (α)
Selectivity parameter is a measure of separation of two compounds in the sample under given conditions. The calculated selectivity parameter for separation of each compound is represented in Table 5 .
Capacity factor (k') Capacity factor (retention factor) is a measure of the retention time of a compound in the sample with a given combination of mobile phase and column. Calculated k' values are represented in Table 5 .
Tailing factor (T) Tailing factor refers to peak asymmetry. Many chromatographic peaks do not appear in the shape of normal Gaussian distribution. Therefore, tailing factor should be calculated. A tailing factor of 1 refers to a symmetric peak. The calculated values for each compound is in the acceptable range and is represented in Table 5 .
Number of theoretical plates (Column efficiency) (N)
In particular separation, column efficiency refers to the performance of the stationary phase. It refers to how well the column is packed. The N values for each compound are represented in Table 5 .
conclusion
The proposed RP-LC method provides accurate, reproducible, and specific stability indicating assay method (SIAM), where the method is able to determine Cinn in presence of its reported degradation products, excipients, additives, Pira, and Hept. No methods have previously been reported for the determination of Cinn in presence of its degradation products, Pira and Hept. The results obtained from this method were compared with those obtained by the official methods and show no significance difference. The method can be applied for the determination of both drugs in pharmaceutical dosage form in routine work and quality control laboratories. 
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